Prostate Cancer Market Report: Trends, Forecast and Competitive Analysis to 2030

Prostate Cancer Trends and Forecast

The future of the global prostate cancer market looks promising with opportunities in the hospital pharmacies, drug store & retail pharmacies, and online pharmacies markets. The global prostate cancer market is expected to reach an estimated $19.47 billion by 2030 with a CAGR of 8.7% from 2024 to 2030. The major drivers for this market are growing incidence of prostate cancer driving the need for advanced prostate treatments, prostate cancer medications advancing through phase III clinical trials, and enhancing funding for research & development and advancements in treatment technology.

A more than 150-page report is developed to help in your business decisions.

Prostate Cancer by Segment

The study includes a forecast for the global prostate cancer by drug class, distribution channel, and region.

Prostate Cancer Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

• Hormonal ADT
• AR-Directed Therapies
• Cytotoxic Agents
• Bone Metastases
• Therapeutic Vaccines
• PARP Inhibitors
• Kinase Inhibitors
• PSMA-Targeted Radioligands

Prostate Cancer Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacies
• Drug store & Retail Pharmacies
• Online Pharmacies

Prostate Cancer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Prostate Cancer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies prostate cancer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the prostate cancer companies profiled in this report include-

• Ferring Pharmaceuticals
• Johnson & Johnson
• Merck
• Pfizer
• Sanofi
• Abbvie
• Astellas Pharma
• Astrazeneca
• Bayer
• Clovis Oncology
• Dendreon Pharmaceuticals

Prostate Cancer Market Insights

Lucintel forecasts that AR-directed therapies is expected to witness highest growth over the forecast period.

APAC is expected to witness highest growth over the forecast period due to The increasing prevalence of prostate cancer, the availability of several treatment choices, technical developments, customized medications, and affordable therapy.

Features of the Global Prostate Cancer Market

Market Size Estimates: Prostate cancer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Prostate cancer market size by drug class, distribution channel, and region in terms of value ($B).

Regional Analysis: Prostate cancer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drug class, distribution channel, and regions for the prostate cancer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the prostate cancer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the prostate cancer market size?

Answer: The global prostate cancer market is expected to reach an estimated $19.47 billion by 2030.

Q.2 What is the growth forecast for prostate cancer market?

Answer: The global prostate cancer market is expected to grow with a CAGR of 8.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the prostate cancer market?

Answer: The major drivers for this market are growing incidence of prostate cancer driving the need for advanced prostate treatments, prostate cancer medications advancing through phase III clinical trials, and enhancing funding for research & development and advancements in treatment technology.

Q4. What are the major segments for prostate cancer market?

Answer: The future of the prostate cancer market looks promising with opportunities in the hospital pharmacies, drug store & retail pharmacies, and online pharmacies markets.

Q5. Who are the key prostate cancer market companies?

Answer: Some of the key prostate cancer companies are as follows.

• Ferring Pharmaceuticals
• Johnson & Johnson
• Merck
• Pfizer
• Sanofi
• AbbVie
• Astellas Pharma
• AstraZeneca
• Bayer
• Clovis Oncology

Q6. Which prostate cancer market segment will be the largest in future?

Answer: Lucintel forecasts that ar-directed therapies is expected to witness highest growth over the forecast period.

Q7. In prostate cancer market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to The increasing prevalence of prostate cancer, the availability of several treatment choices, technical developments, customized medications, and affordable therapy

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the prostate cancer market by drug class (hormonal ADT, AR-directed therapies, cytotoxic agents,bone metastases, therapeutic vaccines, PARP inhibitors, kinase inhibitors, and PSMA-targeted radioligands), distribution channel (hospital pharmacies, drug store & retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?